−3.40TWD
−237.69 MTWD
43.49 MTWD
About ENIMMUNE CORPORATI
Sector
Industry
CEO
Che Wei Chang
Website
Headquarters
Taipei
Founded
2014
ISIN
TW0006564008
FIGI
BBG00M0C0FW5
Enimmune Corp. engages in the research, development of new drugs. Its products include EV71, Japanese encephalitis virus, EV71+CA16 bivalent, tetanus toxoid adsorbed, influenza, AH1N1, and pneumococcal vaccines. The company operates pharmaceutical outlets. Enimmune was founded on January 10, 2014 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6564 is 33.15 TWD — it has decreased by 0.75% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange ENIMMUNE CORPORATI stocks are traded under the ticker 6564.
6564 stock is 3.48% volatile and has beta coefficient of 0.32. Check out the list of the most volatile stocks — is ENIMMUNE CORPORATI there?
Yes, you can track ENIMMUNE CORPORATI financials in yearly and quarterly reports right on TradingView.
6564 stock has risen by 2.63% compared to the previous week, the month change is a 0.79% fall, over the last year ENIMMUNE CORPORATI has showed a 33.90% decrease.
6564 net income for the last quarter is −152.36 M TWD, while the quarter before that showed −77.71 M TWD of net income which accounts for −96.06% change. Track more ENIMMUNE CORPORATI financial stats to get the full picture.
Today ENIMMUNE CORPORATI has the market capitalization of 2.38 B, it has decreased by 0.91% over the last week.
No, 6564 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6564 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENIMMUNE CORPORATI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENIMMUNE CORPORATI technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENIMMUNE CORPORATI stock shows the sell signal. See more of ENIMMUNE CORPORATI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.